| Identification | Back Directory | [Name]
BMS 188107 | [CAS]
139232-80-7 | [Synonyms]
BMS 188107
5H-Pyrano[3,2-c]quinolin-5-one, 2,3,4,6-tetrahydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-6-(phenylmethyl)-, (3R,4S)-rel- | [Molecular Formula]
C25H26N2O4 | [MOL File]
139232-80-7.mol | [Molecular Weight]
418.48 |
| Hazard Information | Back Directory | [Description]
Bms 188107 is a calcium antagonist with cardioprotective effects. | [Uses]
BMS-188107 is a calcium antagonist that exerts anti-ischemic effects. BMS-188107 improves postischemic contractile function and reduces lactate dehydrogenase release. BMS-188107 can be utilized in cardiovascular research[1]. | [References]
[1] Grover GJ, et al. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim. J Pharmacol Exp Ther. 1993 Oct;267(1):102-7. PMID:8229736 |
|
|